Innovative DNA Technologies INOVIO specializes in developing DNA-based medicines, representing a significant opportunity for partnerships and service providers in biotech R&D, high-throughput manufacturing, and advanced laboratory technologies.
Active Industry Engagement The company's frequent participation in major biotech and healthcare conferences indicates ongoing market visibility and networking potential, ideal for establishing strategic collaborations or technology integrations.
Recent Funding & Growth With a recent $30 million public offering, INOVIO is positioned for expansion in research and development efforts, providing opportunities for investors and service providers to support their product pipeline and clinical trials.
Technological Sophistication Utilizing modern tools like Kubernetes, cloud services, and PWA frameworks shows their commitment to innovative IT solutions, which can open doors for technology vendors offering cloud computing, cybersecurity, and software development services.
Focus on High-Impact Therapies Targeting HPV-related diseases and cancer, INOVIO's focus on high-need medical areas presents opportunities for healthcare providers, pharmaceutical companies, and medical device firms interested in expanding into targeted immunotherapies and vaccine development.
INOVIO Pharmaceuticals, Inc. uses 8 technology products and services including SOLIDWORKS, Ansible, Kubernetes, and more. Explore INOVIO Pharmaceuticals, Inc.'s tech stack below.
| INOVIO Pharmaceuticals, Inc. Email Formats | Percentage |
| First.Last@inovio.com | 64% |
| FLast@inovio.com | 29% |
| Last@inovio.com | 5% |
| FirstLast@inovio.com | 2% |
Biotechnology ResearchPennsylvania, United States201-500 Employees
INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our mission: deliver on the promise of DNA medicine for patients around the world. For more information, visit www.inovio.com.
Company Overview
Media & News
Funding & FinancialsINOVIO Pharmaceuticals, Inc. has raised a total of $25M of funding over 15 rounds. Their latest funding round was raised on Jul 03, 2025 in the amount of $25M.
INOVIO Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M
Funding & FinancialsINOVIO Pharmaceuticals, Inc. has raised a total of $25M of funding over 15 rounds. Their latest funding round was raised on Jul 03, 2025 in the amount of $25M.
INOVIO Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com